
A Lyme disease vaccine has shown efficacy in a clinical trial and paves the way for marketing authorisation, pharmaceutical companies Pfizer and the French Valneva announced on Monday.
Lyme disease is a bacterial illness transmitted to humans through the bite of infected ticks.